A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Gastrodia elata Blume and Glycyrrhiza uralensis Fischer extracts mixture on improvement of Cognitive(memory) Function

Wonkwang University, Gwangju Medical Center0 个研究点目标入组 100 人开始时间: 待定最近更新: 2022年5月30日

试验速览

暂无简介。

•1) Those who complain of subjective memory loss {one or more points in the subjective memory loss questionnaire (SMCQ)}
•2) Those who Korean-Mini Mental State Examination(K-MMSE) results in 18~28 scores
•3) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions.

•1)Patients with a clinically significant disease requiring treatment (i.e., acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
•2)Patients with a history of antipsychotic medication use within 3 months prior to the screening examination
•3)Patients with a history of clinically significant hypersensitivity reactions to drugs and test products
•4)Patients who have participated in other clinical trials within 3 months prior to the screening examination
•5)Patients with a Severe score of 29-63 points as a result of the Depression Scale (BDI) test
•6)Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes

发起方

Wonkwang University, Gwangju Medical Center